Protective effect of bicyclol on liver injury induced by hepatic warm ischemia/reperfusion in rats

Hepatology Research

Volumn 39, Issue 8, 2009, Pages 833-842

  Yao, Xiao Min ^a   Chen, Hui ^a   Li, Yan ^a  

^a INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

Antioxidant; Bicyclol; Ischemia reperfusion; Liver; Nuclear factor B; TLR4

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIOXIDANT; BICYCLOL; BILIRUBIN; ENDOTOXIN; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERCELLULAR ADHESION MOLECULE 1; MALONALDEHYDE; MYELOPEROXIDASE; NITRIC OXIDE; SUPEROXIDE DISMUTASE; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILIRUBIN BLOOD LEVEL; CONTROLLED STUDY; DOSE RESPONSE; DOWN REGULATION; DRUG EFFICACY; DRUG SAFETY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE OVEREXPRESSION; IMMUNOHISTOCHEMISTRY; LIVER FUNCTION; LIVER INJURY; LIVER ISCHEMIA; LIVER PROTECTION; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 68449090432     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2009.00504.x     Document Type: Article

References (36)

1. Skopp G, Schmitt HP, Pedal I. Fulminant liver failure in a patient on carbamazepine and levetiracetam treatment associated with status epilepticus. Arch Kriminol 2006; 217: 161-75.
2. Jaeschke H, Farhood A. Neutrophil and Kupffer cell-induced oxidant stress and ischemia-reperfusion injury in rat liver. Am J Physiol 1991; 260: G355-62.
3. Jaeschke H, Bautista AP, Spolarics Z, Spitzer JJ. Superoxide generation by Kupffer cells and priming of neutrophils during reperfusion after hepatic ischemia. Free Radic Res Commun 1991; 15: 277-84.
4. Jaeschke H, Farhood A, Smith CW. Neutrophils contribute to ischemia/ reperfusion injury in rat liver in vivo. FASEB J 1990; 4: 3355-9.
5. Wanner GA, Ertel W, Müller P et al. Liver ischemia and reperfusion induces a systemic inflammatory response through Kupffer cell activation. Shock 1996; 5: 34-40.
6. Vollmar B, Glasz J, Menger MD, Messmer K. Leukocytes contribute to hepatic ischemia/reperfusion injury via intercellular adhesion molecule-1-mediated venular adherence. Surgery 1995; 117: 195-200.
7. Marubayashi S, Oshiro Y, Maeda T etal. Protective effect of monoclonal antibodies to adhesion molecules on rat liver ischemia-reperfusion injury. Surgery 1997; 122: 45-52.
8. Fondevila C, Busuttil RW, Kupiec-Weglinski JW. Hepatic ischemia/ reperfusion injury-a fresh look. Exp Mol Pathol 2003; 74: 86-93.
9. Tsung A, Hoffman RA, Izuishi K et al. Hepatic ischemia/reperfusion injury involves functional TLR4 signaling in nonparenchymal cells. J Immunol 2005; 175: 7661-8.
10. Asehnoune K, Strassheim D, Mitra S, Kim JY, Abraham E. Involvement of reactive oxygen species in Toll-like receptor 4-dependent activation of NF-kappa B. J Immunol 2004; 172: 2522-9.
11. Liu GT. The anti-virus and hepatoprotective effect of bicyclol and its mechanism of action. Chin J New Drug 2001; 10: 325-7.
12. Liu GT, Li Y, Wei HL, Zhang H, Xu JY, Yu LH. Mechanism of protective action of bicyclol against CCl 4 -induced liver injury in mice. Liver Int 2005; 25: 872-9.
13. Wang HP, Li Y. Protective effect of bicyclol on acute hepatic failure induced by lipopolysaccharide and D-galactosamine in mice. Eur J Pharmacol 2006; 534: 194-201.
14. Zhao DM, Liu GT. Protective effect of bicyclol on concanavalin A induced liver nuclear DNA injury in mice. Zhonghua Yi Xue Za Zhi 2001; 14: 844-8.
15. Liu GT, Li Y, Wei HL et al. Toxicity of novel anti-hepatitis drug bicyclol: A preclinical study. World J Gastroenterol 2005; 11: 665-71.
16. Nakashima Y, Kohno H, EL-Assal ON et al. Sequential changes of connexin32 and connexin26 in ischemia-reperfusion of the liver in rats. Hepatol Res 2003; 27: 67-75.
17. Ogura R, Sakanashi T, Nagata O et al. Assay for lipid peroxide content in mitochondria by the thiobarbituric acid reaction. Kurume Med J 1987; 34: 53-8.
18. Ozturk H, Gezici A, Ozturk H. The effect of celecoxib, a selective COX-2 inhibitor, on liver ischemia/reperfusion-induced oxidative stress in rats. Hepatol Res 2006; 34: 76-83.
19. Li C, Jackson RM. Reactive species mechanisms of cellular hypoxia-reoxygenation injury. Am J Physiol Cell Physiol 2002; 282: C227-41.
20. Chen HM, Chen MF, Shyr MH. Prostacyclin analogue (OP-2507) attenuates hepatic microcirculatory derangement, energy depletion, and lipid peroxidation in a rat model of reperfusion injury. J Surg Res 1998; 80: 333-8.
21. Taylor BS, Geller DA. Molecular regulation of the human inducible nitric oxide synthase (iNOS) gene. Shock 2000; 13: 413-24.
22. Kimura H, Katsuramaki T, Isobe M et al. Role of inducible nitric oxide synthase in pig liver transplantation. J Surg Res 2003; 111: 28-37.
23. Minor T, Isselhard W, Yamamoto Y, Obara M, Saad S. The effects of allopurinol and SOD on lipid peroxidation and energy metabolism in the liver after ischemia in an aerobic/anaerobic persufflation. Surg Today 1993; 23: 728-32.
24. Shin T, Kuboki S, Lentsch AB. Roles of nuclear factor-kappaB in postischemic liver. Hepatol Res 2008; 38: 429-40.
25. Kawai T, Akira S. TLR signaling. Semin Immunol 2007; 19: 24-32.
26. Kojima Y, Suzuki S, Tsuchiya Y, Konno H, Baba S, Nakamura S. Regulation of pro-inflammatory and anti-inflammatory cytokine responses by Kupffer cells in endotoxin-enhanced reperfusion injury after total hepatic ischemia. Transpl Int 2003; 16: 231-40.
27. Glantzounis GK, Salacinski HJ, Yang W, Davidson BR, Seifalian AM. The contemporary role of antioxidant therapy in attenuating liver ischemia-reperfusion injury: A review. Liver Transpl 2005; 11: 1031-47.
28. Sawaya DE Jr, Zibari GB, Minardi A et al. P-selectin contributes to the initial recruitment of rolling and adherent leukocytes in hepatic venules after ischemia/reperfusion. Shock 1999; 12: 227-32.
29. Teoh NC, Farrell GC. Hepatic ischemia reperfusion injury: Pathogenic mechanisms and basis for hepatoprotection. J Gastroenterol Hepatol 2003; 18: 891-902.
30. Mollen KP, Anand RJ, Tsung A, Prince JM, Levy RM, Billiar TR. Emerging paradigm: Toll-like receptor 4-sentinel for the detection of tissue damage. Shock 2006; 26: 430-37.
31. Tsoulfas G, Takahashi Y, Ganster RW et al. Activation of the lipopolysaccharide signaling pathway in hepatic transplantation preservation injury. Transplantation 2002; 74: 7-13.
32. Zhai Y, Shen XD, O'Connell R et al. Cutting edge: TLR4 activation mediates liver ischemia/reperfusion inflammatory response via IFN regulatory factor 3-dependent MyD88-independent pathway. J Immunol 2004; 173: 7115-19.
33. Andrade CF, Waddell TK, Keshavjee S, Liu M. Innate immunity and organ transplantation: The potential role of toll-like receptors. Am J Transplant 2005; 5: 969-75.
34. VajdováK, SmrekováR, Kukan M et al. Endotoxin-induced aggravation of preservation- reperfusion injury of rat liver and its modulation. J Hepatol 2000; 32: 112-20.
35. Ren D, Han D, Zhao Y. Effect of intestinal endotoxemia on hepatic energy metabolism in acute liver failure. Chin J Pathophy 2001; 17: 890-2.
36. Yanagida H, Uchida Y, Yokoigawa N, Kwon AH, Okumura T, Kamiyama Y. Pirfenidone protects endotoxin-induced liver injury after hepatic ischemia in rats. Transplant Proc 2004; 36: 1973-4.